This website uses cookies to ensure you get the best experience on our website.
- Table of Contents
Real validated LRP2 Western blot protocols, expected-band and isoform facts, troubleshooting for weak or shifted signal, and recommended anti-LRP2 WB antibodies. Everything you need to plan the experiment before you commit precious samples.
Expected bands, validated protocols, controls and antibodies — the at-a-glance facts below, then the full design guide.
| Expected band | ~522 kDa | |
| Gel | 4–12% gradient (standard starting point) | |
| Positive control | Kidney (IHC candidate; verify WB) +2 more | |
| Negative control | Adipose tissue (IHC candidate; verify WB) |
| PTM | Glycosylated + Phosphorylated | |
| Caveat | Modification-state controls | |
| Gene-set association | MSigDB C7 membership | |
| Isoform | 1 isoform(s) |
The M02463 protocol combines labelled catalog values with standard starting conditions. Published comparisons retain their own sample, reagent and detection scope.
| Sample / lysate | 293T cell lysate (catalog M02463) |
| Gel % | 4–12% gradient (standard starting point) |
| Load | 20–30 µg total protein per lane; optimize for abundance (standard starting point) |
| Transfer | Wet/tank transfer; optimize duration (standard starting point) |
| Membrane | 0.45 µm PVDF (standard starting point) |
| Blocking | 5% milk or 5% BSA in TBST (standard starting point) |
| Primary antibody | M02463; use the WB datasheet starting dilution (standard starting point) |
| Primary incubation | Overnight at 4 °C (standard starting point) |
| Secondary antibody | Species-matched HRP conjugate at validated dilution (standard starting point) |
| Secondary incubation | 1 h at room temperature (standard starting point) |
| Wash | 3 × 5 min in TBST (standard starting point) |
| Detection | ECL; bracket exposures to avoid saturation (standard starting point) |
LRP2 has a predicted precursor mass of 522 kDa; glycosylation and signal-peptide cleavage may affect migration, but no empirical band or demonstrated shift is supplied.
| Band near 522 kDa | consistent with the predicted full-length LRP2 mass; confirm identity with controls |
| Band above 522 kDa | N-linked glycosylation could affect apparent migration |
| Band slightly below 522 kDa | signal-peptide removal could reduce precursor mass slightly |
| Weak band in whole-cell lysate | apical membrane LRP2 may be poorly represented in the sample |
| Predicted precursor mass | sets a 522 kDa sequence-based reference |
| N-linked glycosylation at Asn159 | could increase apparent size; its individual effect is unknown |
| N-linked glycosylation at Asn178 | could increase apparent size; its individual effect is unknown |
| N-linked glycosylation at Asn299 | could increase apparent size; its individual effect is unknown |
| Signal peptide at residues 1–25 | cleavage makes the mature protein slightly smaller than the precursor |
| Situation | Likely cause | Next action |
|---|---|---|
| No band in lysate | apical membrane LRP2 may be poorly recovered | check a membrane-enriched fraction and a positive-control sample |
| Band higher than expected | N-linked glycosylation may alter migration | compare with a deglycosylated aliquot and confirm band identity |
| Band lower than expected | signal-peptide removal causes a small mass decrease; a larger difference remains unexplained | check antibody specificity and compare with a positive-control sample |
| Broad smear instead of sharp band | variation across N-linked glycosylation sites is possible | compare with a deglycosylated aliquot and check sample integrity |
| Multiple bands | glycosylation or signal-peptide processing may contribute, but distinct bands are unproven | compare bands with a positive-control sample and test antibody specificity |
Comprehensive Human Protein Atlas IHC scoring per tissue. Rows are taken directly from the HPA tissue chart — click any row's HPA link to view the source.
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Kidney | proximal tubules (microvilli) | High | Protein (IHC) | HPA → |
| Parathyroid gland | glandular cells | Medium | Protein (IHC) | HPA → |
| Testis | Leydig cells | Medium | Protein (IHC) | HPA → |
| Tissue | Cell type | Level | Evidence | Source |
|---|---|---|---|---|
| Adipose tissue | adipocytes | Not detected | Protein (IHC) | HPA → |
| Adrenal gland | glandular cells | Not detected | Protein (IHC) | HPA → |
| Appendix | glandular cells | Not detected | Protein (IHC) | HPA → |
| Breast | adipocytes | Not detected | Protein (IHC) | HPA → |
| Bronchus | respiratory epithelial cells | Not detected | Protein (IHC) | HPA → |
Deeper troubleshooting and optimisation questions for LRP2, answered from its protein features.
Catalog antibodies with Western blot application and product-specific WB images. Evaluate suitability with the reported sample, controls and experimental conditions.
The catalog reports one anti-LRP2 antibody, M02463, with reported Human, Mouse, and Rat reactivity. Its Western blot image shows Lrp2 expression in 293T cell lysate; no additional WB validation is supplied.
Which to pick: M02463 is the only listed option. Its WB image uses 293T cell lysate, so consider whether that tested sample and its reported reactivity fit your experiment.